{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:05:13Z","timestamp":1784613913141,"version":"3.55.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Epidemiol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Influenza remains an important cause of morbidity among populations with underlying medical conditions associated with increased risk of severe disease. This study aimed to estimate the size of populations eligible for influenza vaccination according to the Mexican Universal Vaccination Program and to evaluate vaccination coverage gaps among populations at risk in Mexico between 2010 and 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analytical study was conducted using epidemiological and administrative healthcare databases from Mexican public healthcare institutions. Population estimates were constructed using prevalence-based epidemiological projections, healthcare system records, and attended patient data from populations at risk. Descriptive analyses and time-series modeling were performed to evaluate vaccination coverage patterns and healthcare demand over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Across all analyzed populations at risk, the number of individuals receiving healthcare services was consistently lower than the number of notified cases and substantially lower than prevalence-based epidemiological estimates. Vaccination coverage varied considerably across populations at risk and remained incomplete throughout the study period. In 2021, although approximately 12.5 million influenza vaccine doses were administered among populations at risk, a substantial proportion of potentially eligible individuals remained unvaccinated. Forecasting analyses suggested a progressive increase in healthcare demand among populations at risk over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Important gaps persist between the estimated population at risk, diagnosed individuals, healthcare utilization, and influenza vaccination coverage in Mexico. The analytical framework proposed in this study integrates epidemiological prevalence estimates, healthcare utilization patterns, and vaccination data to identify unmet vaccination needs and may support improved public health planning, prioritization strategies, and strengthening of influenza vaccination programs in Mexico and similar settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fepid.2026.1826780","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:35:59Z","timestamp":1784612159000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Estimation of populations at risk for severe influenza and vaccination coverage in Mexico, 2010\u20132021"],"prefix":"10.3389","volume":"6","author":[{"given":"Arturo","family":"Galindo-Fraga","sequence":"first","affiliation":[{"name":"Epidemiology Department, National Institute of Medical Sciences and Nutrition Salvador Zubir\u00e1n","place":["Mexico City, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Luna-Casas","sequence":"additional","affiliation":[{"name":"Estimatio, Health Economics and Outcome Research Services","place":["Mexico City, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Gasca-Pineda","sequence":"additional","affiliation":[{"name":"Sanofi Vaccines","place":["Mexico City, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"S\u00e1nchez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Center for Research on Infectious Diseases, National Institute of Public Health","place":["Cuernavaca, Morelos, Mexico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"B1","year":"2023"},{"key":"B2","year":"2023"},{"key":"B3","year":"2022"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e947","DOI":"10.1093\/cid\/ciab060","article-title":"Effect of vaccination on preventing influenza-associated hospitalizations among children during a severe season associated with B\/Victoria viruses, 2019\u20132020","volume":"73","author":"Campbell","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/cid\/ciab462","article-title":"Influenza vaccine effectiveness for prevention of severe influenza-associated illness among adults in the United States, 2019\u20132020: a test-negative study","volume":"73","author":"Grijalva","year":"2021","journal-title":"Clin Infect Dis"},{"key":"B6","year":""},{"key":"B7","author":"Epidemiolog\u00eda","year":"2023"},{"key":"B8","author":"Epidemiolog\u00eda","year":"2023"},{"key":"B9","year":"2023"},{"key":"B10","author":"Salud","year":"2023"},{"key":"B11","year":""},{"key":"B12","year":""},{"key":"B13","year":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0210353","DOI":"10.1371\/journal.pone.0210353","article-title":"Risk factors associated with severe outcomes in adult hospitalized patients according to influenza type and subtype","volume":"14","author":"Mart\u00ednez","year":"2019","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.5772\/intechopen.87410","article-title":"The effect of influenza virus infection on pregnancy outcomes: a systematic review and meta-analysis of cohort studies","volume":"105","author":"Wang","year":"2021","journal-title":"Int J Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.26633\/RPSP.2025.124","article-title":"Impact of the COVID-19 pandemic on influenza vaccination coverage in Latin America: southern cone, Argentina, Chile, and Uruguay","volume":"49","author":"Bonvehi","year":"2025","journal-title":"Rev Panam Salud P\u00fablica"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7138","DOI":"10.1016\/j.vaccine.2023.10.023","article-title":"Influenza vaccination coverage among persons ages six months and older in the vaccine safety datalink in the 2017\u201318 through 2022\u201323 influenza seasons","volume":"41","author":"Irving","year":"2023","journal-title":"Vaccine"},{"key":"B18","first-page":"185","article-title":"Vaccines against influenza: WHO position paper\u2014May 2022","volume":"97","year":"2022","journal-title":"Wkly Epidemiol Rec"},{"key":"B19","year":"2021"},{"key":"B20","first-page":"205","article-title":"Comportamiento de las temporadas de influenza en m\u00e9xico de 2010 a 2016, an\u00e1lisis y prospectiva","volume":"153","author":"Ruiz-Matus","year":"2017","journal-title":"Gac Med Mex"},{"key":"B21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/1471-2458-6-125","article-title":"Vaccination coverage and reasons for non-vaccination in a district of Istanbul","volume":"6","author":"Torun","year":"2006","journal-title":"BMC Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/tropej\/fmq086","article-title":"Programmatic and beneficiary-related factors for low vaccination coverage in papum pare district, Arunachal Pradesh, India","volume":"57","author":"Takum","year":"2011","journal-title":"J Trop Pediatr"},{"key":"B23","year":"2020"},{"key":"B24","year":"2023"},{"key":"B25","year":"2024"},{"key":"B26","doi-asserted-by":"publisher","first-page":"s163","DOI":"10.21149\/14832","article-title":"Prevalencia de prediabetes y diabetes en m\u00e9xico. Ensanut 2022","volume":"65","author":"Basto-Abreu","year":"2023","journal-title":"Salud Publica Mex"},{"key":"B27","doi-asserted-by":"publisher","first-page":"s238","DOI":"10.21149\/14809","article-title":"Prevalencia de obesidad y factores de riesgo asociados en adultos mexicanos: resultados de la ensanut 2022","volume":"65","author":"Campos-Nonato","year":"2023","journal-title":"Salud Publica Mex"},{"key":"B28","year":"2022"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"James","year":"2018","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"917","DOI":"10.21149\/11095","article-title":"Encuesta nacional de salud y nutrici\u00f3n 2018\u201319: metodolog\u00eda y perspectivas","volume":"61","author":"Romero-Mart\u00ednez","year":"2019","journal-title":"Salud Publica Mex"},{"key":"B31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.21149\/10752","article-title":"Prevalencia de diabetes y descontrol glucemico en Mexico: resultados de la ensanut 2016","volume":"62","author":"Basto-Abreu","year":"2020","journal-title":"Salud Publica Mex"},{"key":"B32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S2213-8587(20)30269-2","article-title":"Obesity in Mexico: rapid epidemiological transition and food industry interference in health policies","volume":"8","author":"Barquera","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B33","year":"2022"},{"key":"B34","year":"2020"},{"key":"B35","year":"2018"}],"container-title":["Frontiers in Epidemiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fepid.2026.1826780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T05:36:00Z","timestamp":1784612160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fepid.2026.1826780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":35,"alternative-id":["10.3389\/fepid.2026.1826780"],"URL":"https:\/\/doi.org\/10.3389\/fepid.2026.1826780","relation":{},"ISSN":["2674-1199"],"issn-type":[{"value":"2674-1199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"article-number":"1826780"}}